Suerie Moon, Ph.D.
Affiliations: | 2010 | Harvard University, Cambridge, MA, United States |
Area:
International Relations, International Law and Relations, Public HealthGoogle:
"Suerie Moon"Cross-listing: PHTree
Parents
Sign in to add mentorJohn G. Ruggie | grad student | 2010 | Harvard | |
(Embedding neoliberalism: Global health and the evolution of the global intellectual property regime (1995-2009).) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Large K, Ruiz AA, Slovenski I, et al. (2025) The 30-year evolution of oral cholera vaccines: A case study of a collaborative network alternative innovation model. Plos Global Public Health. 5: e0003599 |
Vieira M, Slovenski I, Large K, et al. (2024) Alternative Pharmaceutical Innovation Models in Competitive Markets: A Collaborative Approach to Develop a Novel Drug for Hepatitis C. Tropical Medicine and Infectious Disease. 9 |
Barber M, Ramachandran R, Moon S. (2024) Estimating The Effects Of COVID-19 On Globalized Markets For Active Pharmaceutical Ingredients. Health Affairs (Project Hope). 43: 959-969 |
Vieira M, Andia T, Karim O, et al. (2023) Rising pharmaceutical innovation in the Global South: a landscape study. Journal of Pharmaceutical Policy and Practice. 16: 155 |
Borghi J, Ismail S, Hollway J, et al. (2022) Viewing the global health system as a complex adaptive system - implications for research and practice. F1000research. 11: 1147 |
Moon S, Armstrong J, Hutler B, et al. (2021) Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability. Lancet (London, England). 399: 487-494 |
Suleman F, Low M, Moon S, et al. (2020) New business models for research and development with affordability requirements are needed to achieve fair pricing of medicines. Bmj (Clinical Research Ed.). 368: l4408 |
Morgan SG, Bathula HS, Moon S. (2020) Pricing of pharmaceuticals is becoming a major challenge for health systems. Bmj (Clinical Research Ed.). 368: l4627 |
Moon S. (2019) Power in global governance: an expanded typology from global health. Globalization and Health. 15: 74 |
Reid MJA, Arinaminpathy N, Bloom A, et al. (2019) Building a tuberculosis-free world: The Lancet Commission on tuberculosis. Lancet (London, England) |